FABP2 and HIV infectious disease: While untreated HIV infection has been associated with a loss of circulating Th17 cells (9), we observed an expansion of circulating Th17 cells and increased Th17/Treg ratios during stable suppressive treatment, which was associated with plasma concentrations of IL-6, CCL20 and the microbial translocation marker IFABP.